Page last updated: 2024-11-03

riluzole and Androgen-Independent Prostatic Cancer

riluzole has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wadosky, KM1
Shourideh, M1
Goodrich, DW1
Koochekpour, S1

Other Studies

1 other study available for riluzole and Androgen-Independent Prostatic Cancer

ArticleYear
Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells.
    The Prostate, 2019, Volume: 79, Issue:2

    Topics: Activating Transcription Factor 6; Androgens; Autophagy; Cell Line, Tumor; Drug Interactions; Endopl

2019